A quick update on all 31 portfolio stocks, including our latest addition

Monthly Portfolio Update: Key Stocks Discussed

During their September meeting, Jim Kramer and Jeff Marks, who oversee portfolio analysis, reviewed their 31 holdings. They’ve considered various factors like Federal Reserve policy, trade moves from Trump, and China’s role, concluding on strategies for the stock market’s last months of 2025.

Here are their updates on specific stocks:

Apple: Jim dismissed Wall Street’s concerns regarding the new iPhone 17. He sees the latest models as a great deal, especially when factoring in trade-in values and carrier promotions from Verizon and T-Mobile. “I can’t wait to upgrade,” he remarked.

Amazon: The stock could see substantial growth if margins improve, which might come from lowering customer service costs on the e-commerce side. They anticipate a growth rebound in the second quarter, especially with Amazon Web Services, which hasn’t kept pace with competitors like Google Cloud and Microsoft Azure.

Abbott Laboratories: While stocks often see fluctuations before integration, they aim to hold onto this high-quality medical and pharmaceutical company, noting its revenue is around 24 times, a rarity in the market.

Broadcom: They remain optimistic about Broadcom’s future and have seen their investment profits increase significantly, so selling isn’t an option.

Boeing: Recently added to their portfolio, they believe the company will gain from Trump’s trade policies and growing aircraft demand. Jim highlighted that this stock has a lot of potential upside compared to others.

BlackRock: Described by Jim as a “bullet market stock,” it has performed well in a strong market, and CEO Larry Fink’s strategy of focusing on high-growth areas like infrastructure makes sense.

Bristol Myers Squibb: Their position is tied to Cobenfy, a schizophrenia treatment that has faced clinical scrutiny. Ongoing research may boost confidence, especially as it also explores applications for Alzheimer’s.

Capital One: Following the acquisition, they are optimistic about this stock, anticipating stock buybacks due to the company’s excess capital. Jim praised the management team, stating, “[CEO] Richard Fairbank is a great operator.”

Costco: Recent stock struggles don’t reflect the company’s business health. It remains a favored choice in the current market landscape.

Salesforce: While its stock may not be the cheapest, Jim recommends it for long-term workplace investment, especially given Cisco’s reliable dividend.

Qnity: Seen as an exciting pure-play in semiconductors, the team believes there’s potential for growth as more customers are likely to enter this fast-evolving sector.

Linde: Despite challenging market conditions, Linde continues to provide value to shareholders. They expect a rebound in market demand eventually.

Microsoft: Viewed as another promising long-term investment, similar to Broadcom. If stock weight becomes too heavy, the underlying reasons for their investment remain intact.

AMD: There’s speculation that AMD could challenge NVIDIA’s dominance in the GPU market. Concerns have been raised regarding Starbucks, particularly about the CEO’s spending habits and their impact on customer acquisition.

In summary, the investment team seems cautiously optimistic but acknowledges the unpredictable nature of the market, highlighting their focus on potential growth sectors while navigating challenges.